BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10499247)

  • 1. Role of interferon-alfa in NHL: still controversial?
    Haase-Statz S; Smalley RV
    Oncology (Williston Park); 1999 Aug; 13(8):1147-59; discussion 1159-60, 1163. PubMed ID: 10499247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV; Andersen JW; Hawkins MJ; Bhide V; O'Connell MJ; Oken MM; Borden EC
    N Engl J Med; 1992 Nov; 327(19):1336-41. PubMed ID: 1406835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimen.
    Smalley RV; Weller E; Hawkins MJ; Oken MM; O'Connell MJ; Haase-Statz S; Borden EC
    Leukemia; 2001 Jul; 15(7):1118-22. PubMed ID: 11455982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma.
    Enschede SH; Shahidi H; Venugopal P; Riley MB; Huang R; Jajeh A; Preisler HD; Gregory SA
    Leuk Lymphoma; 2001 Jan; 40(3-4):325-34. PubMed ID: 11426554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa for the treatment of follicular lymphomas.
    Hiddemann W; Griesinger F; Unterhalt M
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S13-8. PubMed ID: 9672770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant interferon-alpha therapy in patients with follicular lymphoma.
    Ozer H; Wiernik PH; Giles F; Tendler C
    Cancer; 1998 May; 82(10):1821-30. PubMed ID: 9587113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
    Borden EC
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma study group of JCOG.
    Tsukasaki K; Tobinai K; Hotta T; Shimoyama M
    Jpn J Clin Oncol; 2012 Feb; 42(2):85-95. PubMed ID: 22147803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon alpha in the treatment of non-Hodgkin's lymphomas of low malignancy].
    Monnereau A; Soubeyran P; Bonichon F; Eghbali H; Tchen N; Hoerni B
    Bull Cancer; 1998 Oct; 85(10):855-65. PubMed ID: 9835863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in treatment approaches and prognostic factors in aggressive NHL.
    Shipp M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials.
    Griffin MM; Morley N
    Expert Opin Biol Ther; 2013 May; 13(5):803-11. PubMed ID: 23560506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of interferon alfa-2b added to chemotherapy for high-tumor-burden follicular non-Hodgkin's lymphoma.
    Wirt DP; Giles FJ; Oken MM; Solal-Celigny P; Beck JR
    Leuk Lymphoma; 2001 Feb; 40(5-6):565-79. PubMed ID: 11426529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IFN-alpha consolidation after intensive chemotherapy does not bring any survival advantage in low-grade non-Hodgkin lymphoma].
    Klee M; Illiger HJ
    Strahlenther Onkol; 2001 Sep; 177(9):494-5. PubMed ID: 11591024
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
    Bo LJ; Liang AB; Liu B; Chen YH; Wang F; Jin XP
    Ai Zheng; 2006 Dec; 25(12):1553-6. PubMed ID: 17166385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maintenance therapy with rituximab].
    Krankenpfl J; 2005; 43(7-10):222-4. PubMed ID: 16515293
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the role of maintenance rituximab in follicular NHL?
    Maloney DG
    Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.
    Worch J; Rohde M; Burkhardt B
    Pediatr Hematol Oncol; 2013 Sep; 30(6):465-83. PubMed ID: 23570584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.